This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
It is difficult to do scientifically rigorous research on treatments that must be administered urgently or emergently. Therefore, such treatments are often provided without a strong evidence base. Research would be facilitated if it were permissible to waive the requirement for parental consent. However, that raises a different set of concerns. Federal regulations allow waiver of the requirement for consent but only if studies meet certain conditions. Institutional review boards must decide whether those conditions are met. Sometimes, reasonable people disagree. We present and analyze a protocol for which investigators request a waiver of consent.
- Accepted April 2, 2014.
- Copyright © 2014 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
- Article
- Abstract
- The Case
- Does the Research Minimize Risks by Using Sound Scientific Design?
- Are the Risks of the Research Reasonable in Relation to the Anticipated Benefits?
- Does the Research Meet Federal Requirements (Subpart D) for Protecting Children as Research Subjects?
- Will Informed Consent Be Obtained and Documented From Each Prospective Subject?
- Conclusions
- Footnotes
- References
- Info & Metrics
- Comments